Oral antifungals as prophylaxis in haematological malignancy
- 31 March 2001
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 15 (1) , 1-8
- https://doi.org/10.1054/blre.2001.0145
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiationBone Marrow Transplantation, 1998
- Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial ChemotherapyJournal of Antimicrobial Chemotherapy, 1997
- Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALLAnnals of Hematology, 1995
- An autopsy study of systemic fungal infections in patients with hematologic malignanciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Pharmacokinetic Optimisation of Oral Antifungal TherapyClinical Pharmacokinetics, 1993
- Plasma itraconazole concentrations in neutropenic patients after repeated high-dose treatmentEuropean Journal Of Cancer, 1992
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma LevelsMycoses, 1989
- Ketoconazole pharmacokinetics during chronic dosing in adults with haematological malignancyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Clinical Pharmacokinetics of Systemic Antifungal DrugsClinical Pharmacokinetics, 1983